Scarica l'app Stockscreener
12.56
0.31%
-0.19
Design Therapeutics Inc Azioni (DSGN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.91%
18.17
|
19.31 | 21.57 | 20.42 | 16.69 |
| Operating Income/Loss |
5.91%
-18.17
|
-19.31 | -21.57 | -20.42 | -16.69 |
| Income/Loss From Continuing Operations Before Tax |
5.88%
-16.00
|
-17.00 | -19.08 | -17.71 | -13.65 |
| Income/Loss From Continuing Operations After Tax |
5.88%
-16.00
|
-17.00 | -19.08 | -17.71 | -13.65 |
|
Net Income/Loss
|
5.88%
-16.00
|
-17.00 | -19.08 | -17.71 | -13.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.17%
0.4734
|
56.95 | 56.86 | 56.76 | 0.0318 |
| Diluted Average Shares |
99.17%
0.4734
|
56.95 | 56.86 | 56.76 | 0.0318 |
| Basic Earnings Per Share |
10.00%
-0.27
|
-0.30 | -0.34 | -0.31 | -0.24 |
| Diluted Earnings Per Share |
10.00%
-0.27
|
-0.30 | -0.34 | -0.31 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.12%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):